METHOD FOR EVALUATING VASCULAR ENDOTHELIUM FUNCTION AND A SYSTEM THEREFOR
    2.
    发明申请
    METHOD FOR EVALUATING VASCULAR ENDOTHELIUM FUNCTION AND A SYSTEM THEREFOR 有权
    评估血管内皮功能的方法及其系统

    公开(公告)号:US20120310057A1

    公开(公告)日:2012-12-06

    申请号:US13483625

    申请日:2012-05-30

    IPC分类号: A61B5/1455

    摘要: A method for evaluating vascular endothelium function in a human subject comprises monitoring changes in intensity of NADH fluorescence signal emitted from skin tissue cells of an upper limb of said subject as a function of time, wherein said changes result from reactive hyperaemia caused by blocking and releasing blood flow in the same upper limb of said subject. A system for evaluating vascular endothelium function in a human subject comprises a means for illuminating a skin on an upper limb of said subject with exciting light, a means for measuring intensity of fluorescence signal emitted from the skin and recording changes of said intensity of the fluorescence signal over time; and a restriction means for blocking and releasing blood flow in the upper limb of said subject.

    摘要翻译: 用于评价人受试者的血管内皮功能的方法包括监测作为时间的函数从所述受试者的上肢的皮肤组织细胞发射的NADH荧光信号的强度变化,其中所述变化来自由阻断和释放引起的反应性高血钾 所述受试者的上肢的血液流动。 用于评估人类受试者的血管内皮功能的系统包括用激发光照亮所述受试者的上肢皮肤的装置,用于测量从皮肤发出的荧光信号的强度并记录所述荧光强度的变化的装置 信号随着时间推移; 以及用于阻断和释放所述受试者的上肢中的血液流动的限制装置。

    METHOD FOR INHIBITING AND/OR PREVENTING FORMATION OF CANCER METASTASES AND SECONDARY MALIGNANT CANCER
    4.
    发明申请
    METHOD FOR INHIBITING AND/OR PREVENTING FORMATION OF CANCER METASTASES AND SECONDARY MALIGNANT CANCER 审中-公开
    用于抑制和/或预防癌症癌症和次要恶性肿瘤的形成的方法

    公开(公告)号:US20110201653A1

    公开(公告)日:2011-08-18

    申请号:US13094575

    申请日:2011-04-26

    CPC分类号: A61K31/4425

    摘要: The invention relates to a method for inhibiting and/or preventing formation of cancer metastases and secondary malignant cancers by administration to a subject of an effective amount of a quaternary pyridinium salt of formula I wherein R′ is selected from the group consisting of H, OH, CONH2, COCH3, R″ is selected from the group consisting of H, CH3, R′″ represents H or CH3, and X− is a pharmaceutically acceptable counterion.

    摘要翻译: 本发明涉及一种通过向受试者施用有效量的式I的季吡啶鎓盐来抑制和/或预防癌症转移和继发性恶性肿瘤形成的方法,其中R'选自H,OH ,CONH 2,COCH 3,R“选自H,CH 3,R'”表示H或CH 3,X-是药学上可接受的抗衡离子。

    Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection
    5.
    发明授权
    Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection 有权
    使用季铵吡啶化合物进行血管保护和/或肝保护

    公开(公告)号:US07893095B2

    公开(公告)日:2011-02-22

    申请号:US12038381

    申请日:2008-02-27

    IPC分类号: A61K31/44

    CPC分类号: A61K31/4425 A61K31/444

    摘要: The invention relates to a method for the treatment or prevention of diseases or conditions associated with vascular endothelium dysfunction or liver injury comprising the administration to a patient in a need of such treatment or prevention of a therapeutically or prophylactically effective amount of a compound selected from the group consisting of: wherein R represents hydrogen atom, CH3, OH, pyridyl (C5H4N), 1-methylpyridyl (C5H4N—CH3) or pyridyl substituted with hydroxy group ((OH)C5H3N), and X represents a physiologically acceptable counterion.

    摘要翻译: 本发明涉及用于治疗或预防与血管内皮功能障碍或肝损伤相关的疾病或病症的方法,其包括向患者施用需要这种治疗或预​​防治疗或预防有效量的选自 其中R代表氢原子,CH3,OH,吡啶基(C5H4N),1-甲基吡啶基(C5H4N-CH3)或被羟基((OH)C5H3N)取代的吡啶基,X代表生理上可接受的抗衡离子。

    Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection
    6.
    发明授权
    Use of quaternary pyridinium compounds for vasoprotection and/or hepatoprotection 失效
    使用季铵吡啶化合物进行血管保护和/或肝保护

    公开(公告)号:US08377972B2

    公开(公告)日:2013-02-19

    申请号:US13011364

    申请日:2011-01-21

    IPC分类号: A61K31/44

    CPC分类号: A61K31/4425 A61K31/444

    摘要: The invention relates to a method for the treatment or prevention of diseases or conditions associated with vascular endothelium dysfunction or liver injury comprising the administration to a patient in a need of such treatment or prevention of a therapeutically or prophylactically effective amount of a compound selected from the group consisting of: wherein R represents hydrogen atom, CH3, OH, pyridyl (C5H4N), 1-methylpyridyl (C5H4N—CH3) or pyridyl substituted with hydroxy group ((OH)C5H3N), and X represents a physiologically acceptable counterion.

    摘要翻译: 本发明涉及用于治疗或预防与血管内皮功能障碍或肝损伤相关的疾病或病症的方法,其包括向患者施用需要这种治疗或预​​防治疗或预防有效量的选自 其中R代表氢原子,CH3,OH,吡啶基(C5H4N),1-甲基吡啶基(C5H4N-CH3)或被羟基((OH)C5H3N)取代的吡啶基,X代表生理上可接受的抗衡离子。

    Method for evaluating vascular endothelium function and a system therefor
    8.
    发明授权
    Method for evaluating vascular endothelium function and a system therefor 有权
    血管内皮功能评估方法及其系统

    公开(公告)号:US09155472B2

    公开(公告)日:2015-10-13

    申请号:US13483625

    申请日:2012-05-30

    摘要: A method for evaluating vascular endothelium function in a human subject comprises monitoring changes in intensity of NADH fluorescence signal emitted from skin tissue cells of an upper limb of said subject as a function of time, wherein said changes result from reactive hyperaemia caused by blocking and releasing blood flow in the same upper limb of said subject. A system for evaluating vascular endothelium function in a human subject comprises a means for illuminating a skin on an upper limb of said subject with exciting light, a means for measuring intensity of fluorescence signal emitted from the skin and recording changes of said intensity of the fluorescence signal over time; and a restriction means for blocking and releasing blood flow in the upper limb of said subject.

    摘要翻译: 用于评价人受试者的血管内皮功能的方法包括监测作为时间的函数从所述受试者的上肢的皮肤组织细胞发射的NADH荧光信号的强度变化,其中所述变化来自由阻断和释放引起的反应性高血钾 所述受试者的上肢的血液流动。 用于评估人类受试者的血管内皮功能的系统包括用激发光照亮所述受试者的上肢皮肤的装置,用于测量从皮肤发出的荧光信号的强度并记录所述荧光强度的变化的装置 信号随着时间推移; 以及用于阻断和释放所述受试者的上肢中的血液流动的限制装置。

    Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection
    9.
    发明申请
    Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection 失效
    使用第四纪吡啶鎓化合物进行血管保护和/或肝保护

    公开(公告)号:US20110118316A1

    公开(公告)日:2011-05-19

    申请号:US13011364

    申请日:2011-01-21

    CPC分类号: A61K31/4425 A61K31/444

    摘要: The invention relates to a method for the treatment or prevention of diseases or conditions associated with vascular endothelium dysfunction or liver injury comprising the administration to a patient in a need of such treatment or prevention of a therapeutically or prophylactically effective amount of a compound selected from the group consisting of: wherein R represents hydrogen atom, CH3, OH, pyridyl (C5H4N), 1-methylpyridyl (C5H4N—CH3) or pyridyl substituted with hydroxy group ((OH)C5H3N), and X represents a physiologically acceptable counterion.

    摘要翻译: 本发明涉及用于治疗或预防与血管内皮功能障碍或肝损伤相关的疾病或病症的方法,其包括向患者施用需要这种治疗或预​​防治疗或预防有效量的选自 其中R代表氢原子,CH3,OH,吡啶基(C5H4N),1-甲基吡啶基(C5H4N-CH3)或被羟基((OH)C5H3N)取代的吡啶基,X代表生理上可接受的抗衡离子。

    Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers
    10.
    发明申请
    Method for inhibiting and/or preventing formation of cancer metastases and seconddary malignant cancers 审中-公开
    用于抑制和/或预防癌症转移和二次恶性肿瘤形成的方法

    公开(公告)号:US20090118340A1

    公开(公告)日:2009-05-07

    申请号:US12287671

    申请日:2008-10-09

    IPC分类号: A61K31/4425 A61P35/04

    CPC分类号: A61K31/4425

    摘要: The invention relates to a method for inhibiting and/or preventing formation of cancer metastases and secondary malignant cancers by administration to a subject of an effective amount of a quaternary pyridinium salt of formula I wherein R′ is selected from the group consisting of H, OH, CONH2, COCH3, R″ is selected from the group consisting of H, CH3, R′″ represents H or CH3, and X− is a pharmaceutically acceptable counterion.

    摘要翻译: 本发明涉及一种通过向受试者施用有效量的式I的季吡啶鎓盐来抑制和/或预防癌症转移和继发性恶性肿瘤形成的方法,其中R'选自H,OH ,CONH 2,COCH 3,R“选自H,CH 3,R”'表示H或CH 3,X-是药学上可接受的抗衡离子。